PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Medicine: Alzheimer's and heart attacks share the same genes

'Test ready' according to new study based on controversial statistical techniques

2010-12-10
(Press-News.org) Alzheimer and heart attacks have been found to share common genetic basis. The research leads the way to the first genetic test on developing the risk of the diseases even at a young age. According to Federico Licastro, an immunologist at the University of Bologna who coordinated the study published in the scientific journal, Journal of Alzheimer's Disease, a test is now ready. "They are already selling it in America", he says, citing the case of a private firm in New Mexico (USA) that collaborated on the study. "But the tests could easily be also conducted wherever, using a simple blood test".

It comes as no surprise that the prospect of personalised tests is also very attractive to healthcare companies. Alzheimer and heart attacks are two relatively common diseases, Alzheimer being the most frequent form of senile dementia: by 85, it affects one in five women and one in ten men. Heart attacks, along with other cardiovascular problems, are one of the most widespread diseases and one of the main causes of death, affecting approximately 12.5 per cent of the population.

Very little was known to date about the connection between the two diseases. However, some epidemiological data appeared to suggest such a link. For example, coronary problems had already been associated with elevated frequency of Alzheimer, just as other issues such as hypertension, high cholesterol, diabetes and other typical cardiovascular risk factors. Some genes, controlling for inflammatory processes and cholesterol metabolism, were also known to be connected in some way to both Alzheimer and heart attacks.

What the researchers did was to examine the DNA of 1800 people (280 of whom had suffered a heart attack, 257 Alzheimer and 1307 healthy subjects, used as a control group), in their search for genetic factors suggesting a risk common to the two diseases. Their research proved positive; indeed there is some overlapping between the congenital risks of being affected by Alzheimer and suffering a heart attack. This common genetic predisposition was found in 30 percent of heart attack sufferers and 40 per cent of those affected by Alzheimer. To reach this conclusion, the researches separated all those tested into six groups, with varying levels of risk; low for groups one, two and three; groups two and three only being classified as low risk under the age of 65. Groups four, five and six were classified as high; group five only having a high risk of suffering a heart attack (over the age of 55). Groups four and six, on the other hand, were the two main groups that the researchers focused on. Both had a high risk of suffering a heart attack (under the age of 40 in group four and between the ages of 40 and 54 in group six) as well as Alzheimer (under the age of 65 in group four and over it, in group six). Indeed, it was these last two groups that showed a common genetic predisposition.

"Until now, we only knew about individual genes linked to both diseases and this was not sufficient to develop an individual test for the risk", explained Licastro. "However, we have now been able to identify a genetic profile of several genes partially common to both diseases. This is the leap in quality that now enables us to conduct a test and assess a profile partially specific to both diseases".

Based on the result of the test, the researchers say that you can, for example, decide whether or not to monitor the situation by regular medical checks and more in-depth medical exams. Furthermore, the link between the two diseases tells us a bit more about their origin. According to Licastro, "the core of the genetic risk profile consists of genes that are involved in synthesizing and transporting cholesterol and in controlling for inflammation, which, therefore, appears to be at the root of both diseases". This means that not only can you conduct tests to identify the diseases, you can also define appropriate life-styles to prevent heart and circulation problems and Alzheimer.

However, the researchers understand that technical ingredient that brought about the success of the test is likely to be controversial. Indeed, to study the DNA of their patients, they had to resort to an innovative statistical technique called grade of membership analysis. Although this approach is already applied to the study of other problems, from melanomas to schizophrenia, it is still being debated within the international scientific community. "However, it is only by using such statistical analyses", says Licastro, "that such diseases can be tested, conducting tests on only a few hundred cases. Classical statistics would require us to test 10, 12 or even 20 or 30 thousand cases".

In short, the debate is still open. Professor Federico Licastro and his group, which includes the very young Elisa Porcellini and Ilaria Carbone, will continue looking into the question in more depth, hoping to find new genetic links between the two diseases. Critics may contest the statistical results or even put forward counter tests based on classical statistics. For now, however, what everyone seems to agree on is that a healthy life-style that helps keep cholesterol and hypertension under control is not only beneficial to the heart but also to the brain.

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

National team of scientists peers into the future of stem cell biology

2010-12-10
(Santa Barbara, Calif.) –– Remarkable progress in understanding how stem cell biology works has been reported by a team of leading scientists, directed by experts at UC Santa Barbara. Their research has been published in the journal Cell Stem Cell. Stem cell biology is making waves around the world with great hope for the eventual repair of parts of the body. While many scientists see these breakthroughs as viable, there are hurdles that must be overcome, including the worrisome potential for introducing cancer when making a repair to an organ. Significant interdisciplinary ...

Immune system changes linked to inflammatory bowel disease revealed

2010-12-10
Scientists at the Virginia Bioinformatics Institute at Virginia Tech have discovered some of the key molecular events in the immune system that contribute to inflammatory bowel disease. The results, which help researchers move one step further in their efforts to develop new drugs to treat inflammatory and immune-mediated diseases, are reported in the November 2010 edition (http://www.ncbi.nlm.nih.gov/pubmed/21068720) of the journal Mucosal Immunology from the Nature Publishing Group. Inflammatory bowel disease starts when the gut initiates an abnormal immune response ...

Researchers discover how natural drug fights inflammation

2010-12-10
Researchers at the Virginia Bioinformatics Institute at Virginia Tech have discovered how abscisic acid, a natural plant hormone with known beneficial properties for the treatment of disease, helps fight inflammation. The results (http://www.ncbi.nlm.nih.gov/pubmed/210882970), which are published in the November 2010 Journal of Biological Chemistry, reveal important new drug targets for the development of treatments for inflammatory and immune-mediated diseases. The scientists had reported some of the key molecular events in the immune system of mice that contribute to ...

World's smallest battery created at CINT nanotechnology center

2010-12-10
ALBUQUERQUE, N.M. — A benchtop version of the world's smallest battery — its anode a single nanowire one seven-thousandth the thickness of a human hair —has been created by a team led by Sandia National Laboratories researcher Jianyu Huang. To better study the anode's characteristics, the tiny rechargeable, lithium-based battery was formed inside a transmission electron microscope (TEM) at the Center for Integrated Nanotechnologies (CINT), a Department of Energy research facility jointly operated by Sandia and Los Alamos national laboratories. Says Huang of the work, ...

Fahrenheit -459: Neutron stars and string theory in a lab

2010-12-10
DURHAM, N.C. – Using lasers to contain some ultra-chilled atoms, a team of scientists has measured the viscosity or stickiness of a gas often considered to be the sixth state of matter. The measurements verify that this gas can be used as a "scale model" of exotic matter, such as super-high temperature superconductors, the nuclear matter of neutron stars, and even the state of matter created microseconds after the Big Bang. The results may also allow experimental tests of string theory in the future. Duke physicist John Thomas made the viscosity measurements using an ...

Bering Sea chill yields fatter plankton, pollock diet changes

2010-12-10
Despite a 30-year warming trend, the last three years in the Bering Sea have been the coldest on record. A University of Alaska Fairbanks scientist says that the cold temperatures have helped produce larger zooplankton in the Bering Sea, which may affect the way Walleye pollock feed. Alexei Pinchuk, research professional at the UAF Seward Marine Center, has spent the last three years gathering zooplankton samples in the Bering Sea. He and his colleagues have been looking at how changes in temperature in the Bering Sea affect resident zooplankton and, in turn, how those ...

Industry collaboration enhances academic science, sociologist finds

2010-12-10
New research suggests that private industry and academic science pursue different goals with different consequences, but that the two can still be complementary. Over the past three decades, private funding and collaboration in university-based research has risen steadily. That has led to concerns about the independence and integrity of public science. However, University of Chicago sociologist James Evans finds that industry can advance academic science by shaking up its conservative nature and encouraging novel discovery. Evans's research, released today in the American ...

Supercomputing research opens doors for drug discovery

2010-12-10
OAK RIDGE, Tenn., Dec. 9, 2010 -- A quicker and cheaper technique to scan molecular databases developed at the Department of Energy's Oak Ridge National Laboratory could put scientists on the fast track to developing new drug treatments. A team led by Jerome Baudry of the University of Tennessee-ORNL Center for Molecular Biophysics adapted a widely used existing software to allow supercomputers such as ORNL's Jaguar to sift through immense molecular databases and pinpoint chemical compounds as potential drug candidates. The research was published in the Journal of ...

Researcher develops accurate method for detecting dangerous fluoride

Researcher develops accurate method for detecting dangerous fluoride
2010-12-10
Used in the proper amounts, it can make teeth stronger and aid in the treatment of osteoporosis. When excessive amounts are consumed, however, it can be a killer — a carcinogen that causes bone, lung and bladder cancers. The "it" is fluoride, a common additive in most American communities' drinking water and an ingredient in the vast majority of commercially produced adult toothpastes. Determining the level of fluoride, be it in water, consumer products or the human body, is an important and attractive challenge for scientists. To address that, a Florida State University ...

Official food allergy treatment guidelines released

2010-12-10
A collaborative, government-led effort to guide and standardize diagnosis, treatment and management of food allergies has resulted in the release of an official set of recommendations for physicians. The guidelines are being published online this week by the Journal of Allergy and Clinical Immunology (JACI), and available online at www.niaid.nih.gov/topics/foodallergy/clinical/Pages/default.aspx. They were developed by the National Institutes of Health and leading researchers and clinicians, professional and patient advocacy organizations, and the American Academy of ...

LAST 30 PRESS RELEASES:

Students with multiple marginalized identities face barriers to sports participation

Purdue deep-learning innovation secures semiconductors against counterfeit chips

Will digital health meet precision medicine? A new systematic review says it is about time

Improving eye tracking to assess brain disorders

Hebrew University’s professor Haitham Amal is among a large $17 million grant consortium for pioneering autism research

Scientists mix sky’s splendid hues to reset circadian clocks

Society for Neuroscience 2024 Outstanding Career and Research Achievements

Society for Neuroscience 2024 Early Career Scientists’ Achievements and Research Awards

Society for Neuroscience 2024 Education and Outreach Awards

Society for Neuroscience 2024 Promotion of Women in Neuroscience Awards

Baek conducting air quality monitoring & simulation analysis

Albanese receives funding for scholarship grant program

Generative AI model study shows no racial or sex differences in opioid recommendations for treating pain

New study links neighborhood food access to child obesity risk

Efficacy and safety of erenumab for nonopioid medication overuse headache in chronic migraine

Air pollution and Parkinson disease in a population-based study

Neighborhood food access in early life and trajectories of child BMI and obesity

Real-time exposure to negative news media and suicidal ideation intensity among LGBTQ+ young adults

Study finds food insecurity increases hospital stays and odds of readmission 

Food insecurity in early life, pregnancy may be linked to higher chance of obesity in children, NIH-funded study finds

NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry

New study reveals changes in the brain throughout pregnancy

15-minute city: Why time shouldn’t be the only factor in future city planning

Applied Microbiology International teams up with SelectScience

Montefiore Einstein Comprehensive Cancer Center establishes new immunotherapy institute

New research solves Crystal Palace mystery

Shedding light on superconducting disorder

Setting the stage for the “Frankfurt Alliance”

Alliance presents final results from phase III CABINET pivotal trial evaluating cabozantinib in advanced neuroendocrine tumors at ESMO 2024 and published in New England Journal of Medicine

X.J. Meng receives prestigious MERIT Award to study hepatitis E virus

[Press-News.org] Medicine: Alzheimer's and heart attacks share the same genes
'Test ready' according to new study based on controversial statistical techniques